Actively Recruiting
Comprehensive Assessment of Cancer Theranostic Response
Led by AIQ Solutions · Updated on 2025-09-09
32
Participants Needed
2
Research Sites
77 weeks
Total Duration
On this page
Sponsors
A
AIQ Solutions
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical study. The primary objective is to investigate intent-to-change treatment decisions after the addition of TRAQinform Theranostics. The exploratory objective is to investigate if treatment efficacy and treatment-related toxicity could be detected by TRAQinform Theranostics following PSMA PET/CT at week 12.
CONDITIONS
Official Title
Comprehensive Assessment of Cancer Theranostic Response
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older and willing and able to provide informed consent.
- Diagnosis of metastatic prostate cancer.
- Planned to start 177Lu-PSMA (Pluvicto) treatment.
- Ability to tolerate two 68Ga-PSMA or 18F-DCFPyL PET/CT imaging procedures, one at baseline and one at 12 weeks.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 at screening.
You will not qualify if you...
- Any concurrent disease, infection, or comorbid condition that interferes with the ability to participate in the trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Weill Medical College of Cornell
New York, New York, United States, 10065
Actively Recruiting
2
M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
D
Dona Alberti, RN, MSN
CONTACT
T
Tim Perk, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here